First-Person Psychopharmacology (1PPP): A New Way Forward for Clinical Trials
Journal of Humanistic Psychology June 19, 2026 Radosław Stupak, Pesach Lichtenberg
Psychiatric drug research has limited effectiveness because it relies on symptom-scale trials and biological reductionism that miss the subjective, context-dependent nature of medication effects. A proposed methodology, First-Person Psychopharmacology (1PPP), combines the rigor of randomized controlled trials with qualitative, idiographic methods to study how psychoactive substances alter consciousness, emotion, and behavior in real-life contexts, focusing on personal meaning, social situation, and narrative frameworks. Using a mixed design with multiple experimental groups, interviews, and interpretative and quantitative analyses, 1PPP aims to provide a more ecologically valid and person-centered alternative. Putting the psyche back into psychopharmacology is essential for advancing a humanistic and scientifically robust understanding of psychiatric medications.